Publication
HHS delegates exclusion authority to CMS
HHS Secretary Robert F. Kennedy Jr. announced that the CMS would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately.”
Global | Publication | April 2026
On April 2, 2026, President Trump issued two proclamations under Section 232 of the Trade Expansion Act of 1962 that make significant changes to the Section 232 tariff landscape.
The first presidential proclamation modifies existing Section 232 tariffs on steel, aluminum and copper, effective April 6, 2026 (the Metals Proclamation), and resolves key ambiguities regarding how importers should assess and apply these tariffs.
The second presidential proclamation imposes new Section 232 tariffs on patented pharmaceuticals and associated ingredients, with tariffs taking effect on July 31, 2026 for certain named companies and September 29, 2026 for all others (the Pharmaceuticals Proclamation).
The Metals Proclamation overhauls the existing Section 232 tariff framework for steel, aluminum and copper articles and related derivative products, which, since last year, have been subject to 50 percent tariffs assessed against the value of their steel, aluminum and/or copper content. The Metals Proclamation simplifies this framework by:
These modifications took effect as of 12:01 am eastern time on April 6, 2026.
Specifically, the proclamation establishes the following flat rate structure for Section 232 tariffs on steel, aluminum and copper, as detailed in the Annexes to the proclamation:
The shift to a flat rate assessed against the full entered value of the product resolves key ambiguities that importers have faced in determining the “value” of the steel, aluminum and/or copper content in a derivative product in light of inconsistent guidance from US Customs and Border Protection (CBP) on the topic and related litigation at the Court of International Trade (CIT).
The proclamation also addresses challenges importers faced having to declare minimal steel aluminum and copper content in certain derivative imports. Under the new rules, derivative products classified outside HTSUS Chapters 72, 73, 74 and 76, will only be subject to the 25 percent tariff where the aggregate weight of steel, aluminum and/or copper (insofar as the product is on each of those derivative lists) is at least 15 percent of the total weight of the article. Products below this threshold are no longer subject to Section 232 metals tariffs.
If a product appears on multiple derivative lists, that product will only be subject to these tariffs once. For example, if a product is included on both the steel and aluminum derivative lists and meets or exceeds the weight threshold, it is subject to the applicable 25 percent rate only once.
The proclamation also removes a significant number of products from the derivative tariff lists (as detailed in Annex II), including certain food preparations, paints and coatings, cosmetics and personal care products, soaps and detergents, adhesives, pesticides and disinfectants, antifreezing preparations, fire extinguishers, motorcycles and motorcycle parts imported for manufacturing, cast iron cookware, tanks and armored fighting vehicles and various sporting goods.
The prior process where industry could submit recommendations for additions to the derivatives list has been abolished in favor of a more limited process where the Secretary of Commerce and the US Trade Representative (USTR) must jointly agree to any additions to the derivative lists.
To prepare for these changes, importers should:
Under the Pharmaceuticals Proclamation, 100 percent Section 232 tariffs will be imposed on certain patented pharmaceuticals, together with their associated ingredients (that is, APIs and key starting materials). The tariffs apply to patented pharmaceutical products and related ingredients classifiable under more than 130 specified HTSUS subheadings spanning chapters 29 (organic chemicals) and 30 (pharmaceutical products), as enumerated in the Annexes to the Proclamation. For 17 named major drug companies, these tariffs will take effect on July 31, 2026 (120 days from the proclamation), and for all others, these tariffs will take effect on September 29, 2026 (180 days from the proclamation).
The key takeaways from the Pharmaceuticals Proclamation are as follows:
To prepare for these new tariffs, importers should:
If you have questions about how these new tariffs may affect your operations, please reach out to our team. We will continue to monitor developments and provide updates as additional guidance and CBP implementation instructions are issued.
Publication
HHS Secretary Robert F. Kennedy Jr. announced that the CMS would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately.”
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright US LLP 2026